(4R,5S)-4,5-Diphenyl-2-(quinolin-2-yl)-4,5-dihydrooxazole, 97%, 1g

3-(Trifluoromethyl)benzene-1,2-diamine, 95.0%, 250mg

1,4-Dichloro-2-chloromethyl-benzene, 97.0%, 1g

methyl 1-(2,2-difluoroethyl)-1H-pyrazole-5-carboxylate, 250mg

6,7-Methylenedioxy-4-methyl-3-maleimidocoumarin [for HPLC Labeling]>98.0%(HPLC)(N)100mg

Methyl 5-(2,4-difluorophenyl)isoxazole-3-carboxylate, 95.0%, 5g

(Fmoc-Cys-Otbu)2, 97%, 25g

(-)-Menthyl Succinate>98.0%(GC)(T)25g

1-(2-hydroxyethyl)-5-(2-phenylethyl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one, 95.0%, 1g

(4-(Oxazol-5-yl)phenyl)methanol, 95.0%, 100mg

7-Bromo-2-chloroquinoxaline, 95.0%, 1g

4-Chlorbenzoesäure , >=98 %, zur Synthese, 250 g, kunststoffverpackung.

1-(2,3-DIFLUOROPHENYL)CYCLOPENTANEMETHANAMINE HYDROCHLORIDE, 95%, 100mg